Issue 18, 2012

Discovery of a fluorene class of compounds as inhibitors of botulinum neurotoxin serotype E by virtual screening

Abstract

Botulinum neurotoxins are one of the most poisonous biological substances known to humans and present a potential bioterrorism threat. There are no therapeutic interventions developed so far. Here, we report the first small molecule non-peptide inhibitor for botulinum neurotoxin serotype E discovered by structure-based virtual screening and propose a mechanism for its inhibitory activity.

Graphical abstract: Discovery of a fluorene class of compounds as inhibitors of botulinum neurotoxin serotype E by virtual screening

Supplementary files

Article information

Article type
Communication
Submitted
17 Nov 2011
Accepted
06 Jan 2012
First published
10 Jan 2012

Chem. Commun., 2012,48, 2412-2414

Discovery of a fluorene class of compounds as inhibitors of botulinum neurotoxin serotype E by virtual screening

G. Kumar, R. Agarwal and S. Swaminathan, Chem. Commun., 2012, 48, 2412 DOI: 10.1039/C2CC17158A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements